Divi's Laboratories Limited (BOM:532488)

India flag India · Delayed Price · Currency is INR
6,118.35
-11.25 (-0.18%)
At close: Aug 29, 2025
-0.18%
Market Cap1.63T
Revenue (ttm)96.52B
Net Income (ttm)23.06B
Shares Outn/a
EPS (ttm)86.82
PE Ratio70.59
Forward PE60.35
Dividend30.00 (0.48%)
Ex-Dividend DateJul 25, 2025
Volume1,479
Average Volume10,762
Open6,105.05
Previous Close6,129.60
Day's Range6,096.85 - 6,171.00
52-Week Range4,858.05 - 7,077.70
Betan/a
RSI42.59
Earnings DateAug 7, 2025

About Divi's Laboratories

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its pro... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1990
Employees 10,542
Stock Exchange Bombay Stock Exchange
Ticker Symbol 532488
Full Company Profile

Financial Performance

In 2024, Divi's Laboratories's revenue was 93.60 billion, an increase of 19.31% compared to the previous year's 78.45 billion. Earnings were 21.91 billion, an increase of 36.94%.

Financial Statements

News

There is no news available yet.